Creative Medical Technology Holdings (CELZ) Convertible Debt (2017 - 2021)
Creative Medical Technology Holdings' (CELZ) quarterly Convertible Debt came in at $498800.0 in Q4 2021, down 39.99% year-over-year from $831140.0 in Q4 2020, and little changed quarter-over-quarter from $498800.0 in Q3 2021.
Analysis
Creative Medical Technology Holdings (CELZ) Convertible Debt (2017 - 2021) Analysis & Trends
Creative Medical Technology Holdings (CELZ) has reported Convertible Debt for 3 consecutive years, with $498800.0 the latest figure, recorded in Q4 2021.
- On a quarterly basis, Convertible Debt fell 39.99% year-over-year to $498800.0 in Q4 2021; TTM through Dec 2021 was $498800.0, a 39.99% decrease from a year earlier, with the FY2021 full-year figure at $498800.0, down 39.99% from the prior year.
- Convertible Debt was $498800.0 for Q4 2021 at Creative Medical Technology Holdings, roughly flat from $498800.0 in the prior quarter.
- Over five years, Convertible Debt peaked at $831140.0 in Q4 2020 and troughed at $915.0 in Q4 2017.
- A 3-year average of $301617.6 and a median of $238025.0 in 2020 frame the typical range for Convertible Debt.
- The widest YoY moves for Convertible Debt: up 6.39% in 2021, down 50.72% in 2021.
- Over 3 years, Convertible Debt stood at $915.0 in 2017, then surged by 90734.97% to $831140.0 in 2020, then plunged by 39.99% to $498800.0 in 2021.
- The last three Convertible Debt figures came in at $498800.0 (Q4 2021), $498800.0 (Q3 2021), and $157150.0 (Q2 2021), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn |
| 10 | Creative Medical Technology Holdings | 1.48 Mn | 1.50 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | 498,800.00 |
| Sep 30, 2021 | 498,800.00 |
| Jun 30, 2021 | 157,150.00 |
| Mar 31, 2021 | 157,150.00 |
| Dec 31, 2020 | 831,140.00 |
| Sep 30, 2020 | 532,850.00 |
| Jun 30, 2020 | 318,900.00 |
| Dec 31, 2017 | 915.00 |
| Sep 30, 2017 | 14,402.00 |
| Jun 30, 2017 | 6,069.00 |